[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

2017-2022 Global and Japan Blood system drugs Market Analysis Report

August 2017 | 127 pages | ID: 2AE848ADB47EN
JP Research

US$ 3,085.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Blood system drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Blood system drugs market's development status and future trend in the global and Japan. It splits Blood system drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
  • ACTAVIS ELIZABETH
  • AKORN
  • ALLERGAN SALES LLC
  • AMNEAL PHARMS
  • APOTEX
  • ARALEZ PHARMS
  • ASTRAZENECA PHARMS
  • AVEDRO INC
  • BARR
  • BAXTER HLTHCARE
  • BIOKEY
  • BRECKENRIDGE PHARM
  • BRISTOL MYERS SQUIBB
  • CHIESI USA INC
  • CLOVER PHARMS
  • EMCURE PHARMS LTD
  • FERRING PHARMS INC
  • FRESENIUS KABI USA
  • GENENTECH
  • GLAND PHARMA LTD
  • GLENMARK PHARMS LTD
  • HERITAGE PHARMA
  • HOSPIRA
  • INVAGEN PHARMS
  • IPCA LABS LTD
  • LUITPOLD
  • MEDICURE
  • MYLAN
  • NEW RIVER
  • PFIZER
Geographically, this report splits the Global market into the following regions:
  • Asia Pacific
    • Japan
      • Tokyo
      • Yokohama
      • Osaka
      • Nagoya
      • Others
    • China
    • Korea
    • India
    • Others
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Russia
    • Others
  • North America
    • United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Southeast Asia
    • Singapore
    • Malaysia
    • Vietnam
    • Myanmar
    • Thailand
    • Indonesia
    • Philippines
    • Others
  • Middle East & Africa
    • Saudi Arabia
    • Iran
    • UAE
    • Turkey
    • Israel
    • Egypt
    • South Africa
    • Others
On the basis of product, the Blood system drugs market is primarily split into

Blood system drugs Market, by Antianemic Agents
  • Ferrous sulfate
  • Ferrous succinate
  • RHUEPO
  • Iron-dextrin
  • Vitamin B12
  • Folic acid
  • Mecobalamin
  • Cobamamide
  • Epogen/Procrit
  • NeoRecormon
  • Dynepo
  • Eporatio/Biopoin
  • Aranesp/NESP
  • Mircera/CERA
  • Binocrit
  • Abseamed
  • Epoetin Alfa Hexal
  • Retacrit/Silapo
Blood system drugs Market, by Antiplatelet drug
  • Aspirin
  • Dipyridamole
  • Clopidogrel
  • Prasugrel
  • Ticagrelor
  • Glycoprotein
  • Aggrastat
  • Cilostazol
  • Ticlopidine
  • Cangrelor
  • Vorapaxar
  • Atopaxar
  • Sarpogrelate
Blood system drugs Market, by Coagulant Drugs
  • Thrombin
  • Etamsylate
  • Menadione Sodium Bisulfite
  • Vitamin K1
  • Aminomethylbenzoic Acid
  • Desmopressin acetate
  • Human Coagulation Factor
  • Prothrombin Complex
  • Artificial fibrinogen
  • Aminomethylbenzoic Acid
  • Tranexamic acid
  • Aprotinin
  • Aminocaproic Acid
  • Carbazochrome
  • Pituitrin
Blood system drugs Market, by Anticoagulant and thrombolyti
  • heparin
  • urokinase
  • Warfarin
  • Bishydroxycoumarin
  • Streptokinase
  • Silteplase
Blood system drugs Market, by blood volume expander
  • Hydroxyethyl starch 40
  • Dextran
  • Polyglucose
Key Applications
  • department of hematology
  • Internal Medicine
  • department of surgery
  • Pharmacy
  • Hospital


1 BLOOD SYSTEM DRUGS OVERVIEW

1.1 Product Overview and Scope of Blood system drugs
1.2 Global and Japan Blood system drugs Market by Applications/End Users
  1.2.1 Japan Blood system drugs Sales () and Market Share Comparison by Applications (2012-2017)
    1.2.1.1 Japan Blood system drugs Sales () and Market Share by Applications (2012-2017)
    1.2.1.2 Japan Blood system drugs Sales Growth Rate (%) by Applications (2012-2017)
    1.2.1.3 Market Drivers and Opportunities
  1.2.2 Japan Blood system drugs Sales () and Market Share Comparison by Applications (2012-2017)
  1.2.3 Global Blood system drugs Sales by Application (2012-2017)
    1.2.3.1 Global Blood system drugs Sales () and Market Share by Applications (2012-2017)
    1.2.3.2 Global Blood system drugs Sales Growth Rate (%) by Applications (2012-2017)
    1.2.3.3 Market Drivers and Opportunities
  1.2.4 Global Blood system drugs Sales () and Market Share Comparison by Applications (2012-2017)
  1.2.5 department of hematology
  1.2.6 Internal Medicine
  1.2.7 department of surgery
  1.2.8 Pharmacy
  1.2.9 Hospital
1.3 Global and Japan Market Size (Sales and Revenue) of Blood system drugs (2012-2017)
  1.3.1 Japan Market Size (Sales and Revenue) of Blood system drugs (2012-2017)
    1.3.1.1 Japan Blood system drugs Sales () and Growth Rate (%) (2012-2017)
    1.3.1.2 Japan Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)
  1.3.2 Global Market Size (Sales and Revenue) of Blood system drugs (2012-2017)
    1.3.2.1 Global Blood system drugs Sales () and Growth Rate (%) (2012-2017)
    1.3.2.2 Global Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)
1.4 Global and Japan Classification of Blood system drugs by Antianemic Agents
  1.4.1 Japan Blood system drugs Sales () and Market Share by Antianemic Agents (2012-2017)
  1.4.2 Global Blood system drugs Sales () and Market Share by Antianemic Agents (2012-2017)
  1.4.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Antianemic Agents (2012-2017)
  1.4.4 Global Blood system drugs Revenue (Million USD) and Market Share by Antianemic Agents (2012-2017)
  1.4.5 Japan Blood system drugs Price () by Antianemic Agents (2012-2017)
  1.4.6 Global Blood system drugs Price () by Antianemic Agents (2012-2017)
  1.4.7 Japan Blood system drugs Sales Growth Rate (%) by Antianemic Agents (2012-2017)
  1.4.8 Global Blood system drugs Sales Growth Rate (%) by Antianemic Agents (2012-2017)
  1.4.9 Ferrous sulfate
  1.4.10 Ferrous succinate
  1.4.11 RHUEPO
  1.4.12 Iron-dextrin
  1.4.13 Vitamin B12
  1.4.14 Folic acid
  1.4.15 Mecobalamin
  1.4.16 Cobamamide
1.5 Global and Japan Classification of Blood system drugs by Antiplatelet drug
  1.5.1 Japan Blood system drugs Sales () and Market Share by Antiplatelet drug (2012-2017)
  1.5.2 Global Blood system drugs Sales () and Market Share by Antiplatelet drug (2012-2017)
  1.5.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Antiplatelet drug (2012-2017)
  1.5.4 Global Blood system drugs Revenue (Million USD) and Market Share by Antiplatelet drug (2012-2017)
  1.5.5 Japan Blood system drugs Price () by Antiplatelet drug (2012-2017)
  1.5.6 Global Blood system drugs Price () by Antiplatelet drug (2012-2017)
  1.5.7 Japan Blood system drugs Sales Growth Rate (%) by Antiplatelet drug (2012-2017)
  1.5.8 Global Blood system drugs Sales Growth Rate (%) by Antiplatelet drug (2012-2017)
  1.5.9 Aspirin
  1.5.10 Dipyridamole
  1.5.11 Clopidogrel
  1.5.12 Prasugrel
  1.5.13 Ticagrelor
  1.5.14 Cangrelor
  1.5.15 Vorapaxar
  1.5.16 Atopaxar
  1.5.17 Sarpogrelate
1.6 Global and Japan Classification of Blood system drugs by Coagulant Drugs
  1.6.1 Japan Blood system drugs Sales () and Market Share by Coagulant Drugs (2012-2017)
  1.6.2 Global Blood system drugs Sales () and Market Share by Coagulant Drugs (2012-2017)
  1.6.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Coagulant Drugs (2012-2017)
  1.6.4 Global Blood system drugs Revenue (Million USD) and Market Share by Coagulant Drugs (2012-2017)
  1.6.5 Japan Blood system drugs Price () by Coagulant Drugs (2012-2017)
  1.6.6 Global Blood system drugs Price () by Coagulant Drugs (2012-2017)
  1.6.7 Japan Blood system drugs Sales Growth Rate (%) by Coagulant Drugs (2012-2017)
  1.6.8 Global Blood system drugs Sales Growth Rate (%) by Coagulant Drugs (2012-2017)
  1.6.9 Thrombin
  1.6.10 Etamsylate
  1.6.11 Menadione Sodium Bisulfite
  1.6.12 Vitamin K1
  1.6.13 Aminomethylbenzoic Acid
  1.6.14 Desmopressin acetate
  1.6.15 Human Coagulation Factor
  1.6.16 Prothrombin Complex
  1.6.17 Artificial fibrinogen
  1.6.18 Aminomethylbenzoic Acid
  1.6.19 Tranexamic acid
  1.6.20 Aprotinin
  1.6.21 Aminocaproic Acid
  1.6.22 Carbazochrome
  1.6.23 Pituitrin
1.7 Global and Japan Classification of Blood system drugs by Anticoagulant and thrombolytic
  1.7.1 Japan Blood system drugs Sales () and Market Share by Anticoagulant and thrombolytic (2012-2017)
  1.7.2 Global Blood system drugs Sales () and Market Share by Anticoagulant and thrombolytic (2012-2017)
  1.7.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Anticoagulant and thrombolytic (2012-2017)
  1.7.4 Global Blood system drugs Revenue (Million USD) and Market Share by Anticoagulant and thrombolytic (2012-2017)
  1.7.5 Japan Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)
  1.7.6 Global Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)
  1.7.7 Japan Blood system drugs Sales Growth Rate (%) by Anticoagulant and thrombolytic (2012-2017)
  1.7.8 Global Blood system drugs Sales Growth Rate (%) by Anticoagulant and thrombolytic (2012-2017)
  1.7.9 heparin
  1.7.10 urokinase
  1.7.11 Warfarin
  1.7.12 Bishydroxycoumarin
  1.7.13 Streptokinase
  1.7.14 Silteplase
1.8 Global and Japan Classification of Blood system drugs by blood volume expander
  1.8.1 Japan Blood system drugs Sales () and Market Share by blood volume expander (2012-2017)
  1.8.2 Global Blood system drugs Sales () and Market Share by blood volume expander (2012-2017)
  1.8.3 Japan Blood system drugs Revenue (Million USD) and Market Share by blood volume expander (2012-2017)
  1.8.4 Global Blood system drugs Revenue (Million USD) and Market Share by blood volume expander (2012-2017)
  1.8.5 Japan Blood system drugs Price () by blood volume expander (2012-2017)
  1.8.6 Global Blood system drugs Price () by blood volume expander (2012-2017)
  1.8.7 Japan Blood system drugs Sales Growth Rate (%) by blood volume expander (2012-2017)
  1.8.8 Global Blood system drugs Sales Growth Rate (%) by blood volume expander (2012-2017)
  1.8.9 Hydroxyethyl starch
  1.8.10 Dextran
  1.8.11 Polyglucose

2 GLOBAL AND JAPAN BLOOD SYSTEM DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Blood system drugs Market Competition by Players/Manufacturers
  2.1.1 Japan Blood system drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.1.2 Japan Blood system drugs Revenue and Share by Players/Manufacturers (2012-2017)
  2.1.3 Japan Blood system drugs Average Price () by Players/Manufacturers (2012-2017)
  2.1.4 Japan Blood system drugs Market Competitive Situation and Trends
    2.1.4.1 Japan Blood system drugs Market Concentration Rate
    2.1.4.2 Japan Blood system drugs Market Share of Top 3 and Top 5 Players/Manufacturers
    2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
  2.1.5 Japan Players/Manufacturers Blood system drugs Manufacturing Base Distribution, Sales Area, Product Types
2.2 Global Blood system drugs Market Competition by Players/Manufacturers
  2.2.1 Global Blood system drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.2.2 Global Blood system drugs Revenue and Share by Players/Manufacturers (2012-2017)
  2.2.3 Global Blood system drugs Average Price () by Players/Manufacturers (2012-2017)
  2.2.4 Global Blood system drugs Market Competitive Situation and Trends
    2.2.4.1 Global Blood system drugs Market Concentration Rate
    2.2.4.2 Global Blood system drugs Market Share of Top 3 and Top 5 Players/Manufacturers
    2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
  2.2.5 Global Players/Manufacturers Blood system drugs Manufacturing Base Distribution, Sales Area, Product Types

3 GLOBAL AND JAPAN BLOOD SYSTEM DRUGS SALES AND REVENUE BY REGIONS (2012-2017)

3.1 Asia Pacific Blood system drugs Sales and Revenue by Regions (2012-2017)
  3.1.1 Japan Blood system drugs Sales and Revenue (2012-2017)
    3.1.1.1 Japan Blood system drugs Sales () and Market Share (2012-2017)
    3.1.1.2 Japan Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.1.1.3 Japan Blood system drugs Price ()(2012-2017)
  3.1.2 China Blood system drugs Sales and Revenue (2012-2017)
    3.1.2.1 China Blood system drugs Sales () and Market Share (2012-2017)
    3.1.2.2 China Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.1.2.3 China Blood system drugs Price ()(2012-2017)
  3.1.3 Korea Blood system drugs Sales and Revenue (2012-2017)
    3.1.3.1 Korea Blood system drugs Sales () and Market Share (2012-2017)
    3.1.3.2 Korea Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.1.3.3 Korea Blood system drugs Price ()(2012-2017)
  3.1.4 India Blood system drugs Sales and Revenue (2012-2017)
    3.1.4.1 India Blood system drugs Sales () and Market Share (2012-2017)
    3.1.4.2 India Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.1.4.3 India Blood system drugs Price ()(2012-2017)
  3.1.5 Others Blood system drugs Sales and Revenue (2012-2017)
    3.1.5.1 Others Blood system drugs Sales () and Market Share (2012-2017)
    3.1.5.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.1.5.3 Others Blood system drugs Price ()(2012-2017)
3.2 Europe Blood system drugs Sales and Revenue by Regions (2012-2017)
  3.2.1 France Blood system drugs Sales and Revenue (2012-2017)
    3.2.1.1 France Blood system drugs Sales () and Market Share (2012-2017)
    3.2.1.2 France Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.1.3 France Blood system drugs Price ()(2012-2017)
  3.2.2 Germany Blood system drugs Sales and Revenue (2012-2017)
    3.2.2.1 Germany Blood system drugs Sales () and Market Share (2012-2017)
    3.2.2.2 Germany Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.2.3 Germany Blood system drugs Price ()(2012-2017)
  3.2.3 United Kingdom Blood system drugs Sales and Revenue (2012-2017)
    3.2.3.1 United Kingdom Blood system drugs Sales () and Market Share (2012-2017)
    3.2.3.2 United Kingdom Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.3.3 United Kingdom Blood system drugs Price ()(2012-2017)
  3.2.4 Italy Blood system drugs Sales and Revenue (2012-2017)
    3.2.4.1 Italy Blood system drugs Sales () and Market Share (2012-2017)
    3.2.4.2 Italy Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.4.3 Italy Blood system drugs Price ()(2012-2017)
  3.2.5 Russia Blood system drugs Sales and Revenue (2012-2017)
    3.2.5.1 Russia Blood system drugs Sales () and Market Share (2012-2017)
    3.2.5.2 Russia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.5.3 Russia Blood system drugs Price ()(2012-2017)
  3.2.6 Others Blood system drugs Sales and Revenue (2012-2017)
    3.2.6.1 Others Blood system drugs Sales () and Market Share (2012-2017)
    3.2.6.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.6.3 Others Blood system drugs Price ()(2012-2017)
3.3 North America Blood system drugs Sales and Revenue by Regions (2012-2017)
  3.3.1 United States Blood system drugs Sales and Revenue (2012-2017)
    3.3.1.1 United States Blood system drugs Sales () and Market Share (2012-2017)
    3.3.1.2 United States Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.3.1.3 United States Blood system drugs Price ()(2012-2017)
  3.3.2 Canada Blood system drugs Sales and Revenue (2012-2017)
    3.3.2.1 Canada Blood system drugs Sales () and Market Share (2012-2017)
    3.3.2.2 Canada Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.3.2.3 Canada Blood system drugs Price ()(2012-2017)
3.4 Latin America Blood system drugs Sales and Revenue by Regions (2012-2017)
  3.4.1 Brazil Blood system drugs Sales and Revenue (2012-2017)
    3.4.1.1 Brazil Blood system drugs Sales () and Market Share (2012-2017)
    3.4.1.2 Brazil Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.4.1.3 Brazil Blood system drugs Price ()(2012-2017)
  3.4.2 Mexico Blood system drugs Sales and Revenue (2012-2017)
    3.4.2.1 Mexico Blood system drugs Sales () and Market Share (2012-2017)
    3.4.2.2 Mexico Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.4.2.3 Mexico Blood system drugs Price ()(2012-2017)
  3.4.3 Others Blood system drugs Sales and Revenue (2012-2017)
    3.4.3.1 Others Blood system drugs Sales () and Market Share (2012-2017)
    3.4.3.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.4.3.3 Others Blood system drugs Price ()(2012-2017)
3.5 Southeast Asia Blood system drugs Sales and Revenue by Regions (2012-2017)
  3.5.1 Singapore Blood system drugs Sales and Revenue (2012-2017)
    3.5.1.1 Singapore Blood system drugs Sales () and Market Share (2012-2017)
    3.5.1.2 Singapore Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.1.3 Singapore Blood system drugs Price ()(2012-2017)
  3.5.2 Malaysia Blood system drugs Sales and Revenue (2012-2017)
    3.5.2.1 Malaysia Blood system drugs Sales () and Market Share (2012-2017)
    3.5.2.2 Malaysia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.2.3 Malaysia Blood system drugs Price ()(2012-2017)
  3.5.3 Vietnam Blood system drugs Sales and Revenue (2012-2017)
    3.5.3.1 Vietnam Blood system drugs Sales () and Market Share (2012-2017)
    3.5.3.2 Vietnam Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.3.3 Vietnam Blood system drugs Price ()(2012-2017)
  3.5.4 Myanmar Blood system drugs Sales and Revenue (2012-2017)
    3.5.4.1 Myanmar Blood system drugs Sales () and Market Share (2012-2017)
    3.5.4.2 Myanmar Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.4.3 Myanmar Blood system drugs Price ()(2012-2017)
  3.5.5 Thailand Blood system drugs Sales and Revenue (2012-2017)
    3.5.5.1 Thailand Blood system drugs Sales () and Market Share (2012-2017)
    3.5.5.2 Thailand Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.5.3 Thailand Blood system drugs Price ()(2012-2017)
  3.5.6 Indonesia Blood system drugs Sales and Revenue (2012-2017)
    3.5.6.1 Indonesia Blood system drugs Sales () and Market Share (2012-2017)
    3.5.6.2 Indonesia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.6.3 Indonesia Blood system drugs Price ()(2012-2017)
  3.5.7 Philippines Blood system drugs Sales and Revenue (2012-2017)
    3.5.7.1 Philippines Blood system drugs Sales () and Market Share (2012-2017)
    3.5.7.2 Philippines Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.7.3 Philippines Blood system drugs Price ()(2012-2017)
  3.5.8 Others Blood system drugs Sales and Revenue (2012-2017)
    3.5.8.1 Others Blood system drugs Sales () and Market Share (2012-2017)
    3.5.8.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.8.3 Others Blood system drugs Price ()(2012-2017)
3.6 Middle East & Africa Blood system drugs Sales and Revenue by Regions (2012-2017)
  3.6.1 Saudi Arabia Blood system drugs Sales and Revenue (2012-2017)
    3.6.1.1 Saudi Arabia Blood system drugs Sales () and Market Share (2012-2017)
    3.6.1.2 Saudi Arabia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.1.3 Saudi Arabia Blood system drugs Price ()(2012-2017)
  3.6.2 Iran Blood system drugs Sales and Revenue (2012-2017)
    3.6.2.1 Iran Blood system drugs Sales () and Market Share (2012-2017)
    3.6.2.2 Iran Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.2.3 Iran Blood system drugs Price ()(2012-2017)
  3.6.3 UAE Blood system drugs Sales and Revenue (2012-2017)
    3.6.3.1 UAE Blood system drugs Sales () and Market Share (2012-2017)
    3.6.3.2 UAE Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.3.3 UAE Blood system drugs Price ()(2012-2017)
  3.6.4 Turkey Blood system drugs Sales and Revenue (2012-2017)
    3.6.4.1 Turkey Blood system drugs Sales () and Market Share (2012-2017)
    3.6.4.2 Turkey Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.4.3 Turkey Blood system drugs Price ()(2012-2017)
  3.6.5 Israel Blood system drugs Sales and Revenue (2012-2017)
    3.6.5.1 Israel Blood system drugs Sales () and Market Share (2012-2017)
    3.6.5.2 Israel Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.5.3 Israel Blood system drugs Price ()(2012-2017)
  3.6.6 Egypt Blood system drugs Sales and Revenue (2012-2017)
    3.6.6.1 Egypt Blood system drugs Sales () and Market Share (2012-2017)
    3.6.6.2 Egypt Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.6.3 Egypt Blood system drugs Price ()(2012-2017)
  3.6.7 South Africa Blood system drugs Sales and Revenue (2012-2017)
    3.6.7.1 South Africa Blood system drugs Sales () and Market Share (2012-2017)
    3.6.7.2 South Africa Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.7.3 South Africa Blood system drugs Price ()(2012-2017)
  3.6.8 Others Blood system drugs Sales and Revenue (2012-2017)
    3.6.8.1 Others Blood system drugs Sales () and Market Share (2012-2017)
    3.6.8.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.8.3 Others Blood system drugs Price ()(2012-2017)

4 GLOBAL AND JAPAN BLOOD SYSTEM DRUGS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

4.1 ACTAVIS ELIZABETH
  4.1.1 Company Basic Information, Manufacturing Base and Competitors
  4.1.2 Blood system drugs Product Category, Application and Specification
    4.1.2.1 Product A
    4.1.2.2 Product B
  4.1.3 ACTAVIS ELIZABETH Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.1.4 Main Business/Business Overview
4.2 AKORN
  4.2.1 Company Basic Information, Manufacturing Base and Competitors
  4.2.2 Blood system drugs Product Category, Application and Specification
    4.2.2.1 Product A
    4.2.2.2 Product B
  4.2.3 AKORN Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.2.4 Main Business/Business Overview
4.3 ALLERGAN SALES LLC
  4.3.1 Company Basic Information, Manufacturing Base and Competitors
  4.3.2 Blood system drugs Product Category, Application and Specification
    4.3.2.1 Product A
    4.3.2.2 Product B
  4.3.3 ALLERGAN SALES LLC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.3.4 Main Business/Business Overview
4.4 AMNEAL PHARMS
  4.4.1 Company Basic Information, Manufacturing Base and Competitors
  4.4.2 Blood system drugs Product Category, Application and Specification
    4.4.2.1 Product A
    4.4.2.2 Product B
  4.4.3 AMNEAL PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.4.4 Main Business/Business Overview
4.5 APOTEX
  4.5.1 Company Basic Information, Manufacturing Base and Competitors
  4.5.2 Blood system drugs Product Category, Application and Specification
    4.5.2.1 Product A
    4.5.2.2 Product B
  4.5.3 APOTEX Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.5.4 Main Business/Business Overview
4.6 ARALEZ PHARMS
  4.6.1 Company Basic Information, Manufacturing Base and Competitors
  4.6.2 Blood system drugs Product Category, Application and Specification
    4.6.2.1 Product A
    4.6.2.2 Product B
  4.6.3 ARALEZ PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.6.4 Main Business/Business Overview
4.7 ASTRAZENECA PHARMS
  4.7.1 Company Basic Information, Manufacturing Base and Competitors
  4.7.2 Blood system drugs Product Category, Application and Specification
    4.7.2.1 Product A
    4.7.2.2 Product B
  4.7.3 ASTRAZENECA PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.7.4 Main Business/Business Overview
4.8 AVEDRO INC
  4.8.1 Company Basic Information, Manufacturing Base and Competitors
  4.8.2 Blood system drugs Product Category, Application and Specification
    4.8.2.1 Product A
    4.8.2.2 Product B
  4.8.3 AVEDRO INC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.8.4 Main Business/Business Overview
4.9 BARR
  4.9.1 Company Basic Information, Manufacturing Base and Competitors
  4.9.2 Blood system drugs Product Category, Application and Specification
    4.9.2.1 Product A
    4.9.2.2 Product B
  4.9.3 BARR Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.9.4 Main Business/Business Overview
4.10 BAXTER HLTHCARE
  4.10.1 Company Basic Information, Manufacturing Base and Competitors
  4.10.2 Blood system drugs Product Category, Application and Specification
    4.10.2.1 Product A
    4.10.2.2 Product B
  4.10.3 BAXTER HLTHCARE Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.10.4 Main Business/Business Overview
4.11 BIOKEY
4.12 BRECKENRIDGE PHARM
4.13 BRISTOL MYERS SQUIBB
4.14 CHIESI USA INC
4.15 CLOVER PHARMS
4.16 EMCURE PHARMS LTD
4.17 FERRING PHARMS INC
4.18 FRESENIUS KABI USA
4.19 GENENTECH
4.20 GLAND PHARMA LTD
4.21 GLENMARK PHARMS LTD
4.22 HERITAGE PHARMA
4.23 HOSPIRA
4.24 INVAGEN PHARMS
4.25 IPCA LABS LTD
4.26 LUITPOLD
4.27 MEDICURE
4.28 MYLAN
4.29 NEW RIVER
4.30 PFIZER

5 BLOOD SYSTEM DRUGS MANUFACTURING COST ANALYSIS

5.1 Blood system drugs Key Raw Materials Analysis
  5.1.1 Key Raw Materials
  5.1.2 Price Trend of Key Raw Materials
  5.1.3 Key Suppliers of Raw Materials
  5.1.4 Market Concentration Rate of Raw Materials
5.2 Proportion of Manufacturing Cost Structure
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Manufacturing Expenses
5.3 Manufacturing Process Analysis of Blood system drugs

6 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

6.1 Blood system drugs Industrial Chain Analysis
6.2 Upstream Raw Materials Sourcing
6.3 Raw Materials Sources of Blood system drugs Major Players/Manufacturers in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Marketing Channel
  7.1.1 Direct Marketing
  7.1.2 Indirect Marketing
  7.1.3 Marketing Channel Development Trend
7.2 Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Distributors/Traders List

8 MARKET EFFECT FACTORS ANALYSIS

8.1 Technology Progress/Risk
  8.1.1 Substitutes Threat
  8.1.2 Technology Progress in Related Industry
8.2 Consumer Needs/Customer Preference Change
8.3 Economic/Political Environmental Change

9 GLOBAL AND JAPAN BLOOD SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

9.1 Global and Japan Blood system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
9.2 Global and Japan Blood system drugs Sales () Forecast by Type (2017-2022)
  9.2.1 by Antianemic Agents
  9.2.2 by Antiplatelet drug
  9.2.3 by Coagulant Drugs
  9.2.4 by Anticoagulant and thrombolytic
  9.2.5 by blood volume expander
9.3 Global and Japan Blood system drugs Sales () Forecast by Application (2017-2022)
9.4 Global and Japan Blood system drugs Sales () Forecast by Regions (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 METHODOLOGY AND DATA SOURCE

11.1 Methodology/Research Approach
  11.1.1 Research Programs/Design
  11.1.2 Market Size Estimation
  11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
  11.2.1 Secondary Sources
  11.2.2 Primary Sources
11.3 Disclaimer
11.4 Author List
LIST OF TABLES AND FIGURES

Figure Product Picture of Blood system drugs
Table Japan Blood system drugs Sales (Million Units) Comparison by Applications (2012-2017)
Figure Japan Sales Market Share (%) of Blood system drugs by Applications in 2016
Table Global Blood system drugs Sales (Million Units) Comparison by Applications (2012-2017)
Figure Global Sales Market Share (%) of Blood system drugs by Applications in 2016
Figure department of hematology Examples
Table Key Downstream Customer in department of hematology
Figure Internal Medicine Examples
Table Key Downstream Customer in Internal Medicine
Figure department of surgery Examples
Table Key Downstream Customer in department of surgery
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Ferrous sulfate Product Picture
Figure Ferrous succinate Product Picture
Figure RHUEPO Product Picture
Figure Iron-dextrin Product Picture
Figure Vitamin B12 Product Picture
Figure Aspirin Product Picture
Figure Dipyridamole Product Picture
Figure Clopidogrel Product Picture
Figure Prasugrel Product Picture
Figure Ticagrelor Product Picture
Figure Thrombin Product Picture
Figure Etamsylate Product Picture
Figure Menadione Sodium Bisulfite Product Picture
Figure Vitamin K1 Product Picture
Figure Aminomethylbenzoic Acid Product Picture
Figure heparin Product Picture
Figure urokinase Product Picture
Figure Warfarin Product Picture
Figure Bishydroxycoumarin Product Picture
Figure Streptokinase Product Picture
Figure Dextran Product Picture
Figure Polyglucose Product Picture
Table ACTAVIS ELIZABETH Basic Information List
Table ACTAVIS ELIZABETH Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table ACTAVIS ELIZABETH Blood system drugs Sales Growth Rate (%)(2012-2017)
Table ACTAVIS ELIZABETH Blood system drugs Sales Market Share (%) in Japan (2012-2017)
Figure ACTAVIS ELIZABETH Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
Table AKORN Basic Information List
Table AKORN Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table AKORN Blood system drugs Sales Growth Rate (%)(2012-2017)
Table AKORN Blood system drugs Sales Market Share (%) in Japan (2012-2017)
Figure AKORN Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
Table ALLERGAN SALES LLC Basic Information List
Table ALLERGAN SALES LLC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table ALLERGAN SALES LLC Blood system drugs Sales Growth Rate (%)(2012-2017)
Table ALLERGAN SALES LLC Blood system drugs Sales Market Share (%) in Japan (2012-2017)
Figure ALLERGAN SALES LLC Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
Table AMNEAL PHARMS Basic Information List
Table AMNEAL PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table AMNEAL PHARMS Blood system drugs Sales Growth Rate (%)(2012-2017)
Table AMNEAL PHARMS Blood system drugs Sales Market Share (%) in Japan (2012-2017)
Figure AMNEAL PHARMS Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
Table APOTEX Basic Information List
Table APOTEX Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table APOTEX Blood system drugs Sales Growth Rate (%)(2012-2017)
Table APOTEX Blood system drugs Sales Market Share (%) in Japan (2012-2017)
Figure APOTEX Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
Table ARALEZ PHARMS Basic Information List
Table ARALEZ PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table ARALEZ PHARMS Blood system drugs Sales Growth Rate (%)(2012-2017)
Table ARALEZ PHARMS Blood system drugs Sales Market Share (%) in Japan (2012-2017)
Figure ARALEZ PHARMS Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
Table ASTRAZENECA PHARMS Basic Information List
Table ASTRAZENECA PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table ASTRAZENECA PHARMS Blood system drugs Sales Growth Rate (%)(2012-2017)
Table ASTRAZENECA PHARMS Blood system drugs Sales Market Share (%) in Japan (2012-2017)
Figure ASTRAZENECA PHARMS Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
Table AVEDRO INC Basic Information List
Table AVEDRO INC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table AVEDRO INC Blood system drugs Sales Growth Rate (%)(2012-2017)
Table AVEDRO INC Blood system drugs Sales Market Share (%) in Japan (2012-2017)
Figure AVEDRO INC Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
Table BARR Basic Information List
Table BARR Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table BARR Blood system drugs Sales Growth Rate (%)(2012-2017)
Table BARR Blood system drugs Sales Market Share (%) in Japan (2012-2017)
Figure BARR Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
Table BAXTER HLTHCARE Basic Information List
Table BAXTER HLTHCARE Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table BAXTER HLTHCARE Blood system drugs Sales Growth Rate (%)(2012-2017)
Table BAXTER HLTHCARE Blood system drugs Sales Market Share (%) in Japan (2012-2017)
Figure BAXTER HLTHCARE Blood system drugs Revenue Market Share (%) in Japan (2012-2017)
Table BIOKEY Basic Information List
Table BRECKENRIDGE PHARM Basic Information List
Table BRISTOL MYERS SQUIBB Basic Information List
Table CHIESI USA INC Basic Information List
Table CLOVER PHARMS Basic Information List
Table EMCURE PHARMS LTD Basic Information List
Table FERRING PHARMS INC Basic Information List
Table FRESENIUS KABI USA Basic Information List
Table GENENTECH Basic Information List
Table GLAND PHARMA LTD Basic Information List
Table GLENMARK PHARMS LTD Basic Information List
Table HERITAGE PHARMA Basic Information List
Table HOSPIRA Basic Information List
Table INVAGEN PHARMS Basic Information List
Table IPCA LABS LTD Basic Information List
Table LUITPOLD Basic Information List
Table MEDICURE Basic Information List
Table MYLAN Basic Information List
Table NEW RIVER Basic Information List
Table PFIZER Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Blood system drugs
Figure Manufacturing Process Analysis of Blood system drugs
Figure Blood system drugs Industrial Chain Analysis
Table Raw Materials Sources of Blood system drugs Major Players/Manufacturers in 2016
Table Major Buyers of Blood system drugs
Table Distributors/Traders List
Figure Japan Blood system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Japan Blood system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Blood system drugs Price () Trend Forecast (2017-2022)
Figure Global Blood system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Blood system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Blood system drugs Price () Trend Forecast (2017-2022)
Table Japan Blood system drugs Sales () Forecast by Type (2017-2022)
Table Global Blood system drugs Sales () Forecast by Type (2017-2022)
Figure Japan Blood system drugs Sales () Forecast by Type (2017-2022)
Figure Global Blood system drugs Sales () Forecast by Type (2017-2022)
Figure Japan Blood system drugs Sales Volume Market Share Forecast by Type in 2017
Figure Global Blood system drugs Sales Volume Market Share Forecast by Type in 2017
Table Japan Blood system drugs Sales () Forecast by Application (2017-2022)
Figure Japan Blood system drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan Blood system drugs Sales Volume Market Share Forecast by Application in 2017
Table Global Blood system drugs Sales () Forecast by Application (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Blood system drugs Sales Volume Market Share Forecast by Application in 2017
Table Japan Blood system drugs Sales () Forecast by Regions (2017-2022)
Table Japan Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
Table Global Blood system drugs Sales () Forecast by Regions (2017-2022)
Table Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories